Some randomized controlled trials examining different self-titration techniques, most of them with basal or premixed insulin analogues, have found that self-adjustment of insulin is effective in helping patients with T2DM safely meet their treatment goals [9, 13, 20–25]. This evidence concerns the gene INS and type 2 diabetes mellitus.